期刊文献+

门诊高血压患者药物治疗依从性现状及影响因素分析 被引量:8

Outpatient Drug Treatment Compliance in Patients with Hypertension Status and Influencing Factors
下载PDF
导出
摘要 目的:了解并分析高血压药物治疗依从性(CPAT)现状和影响因素。方法:采用自行编制的调查表便利抽样法调查130例来院心血管门诊就诊的高血压患者,以Morisky-Green测评表进行依从性的测定,用SPSS 11.5软件统计分析。结果:(1)130例高血压患者CPAT高者为33.8%(44例),中等者为30%(39例),低者为36.2%(47例)。(2)CPAT影响因素:年龄、婚姻状况、受教育程度、家庭月收入、社区医疗服务状况、病程、疾病症状、药物不良反应、治疗重要性认识、药物知识了解、自测血压情况、家属督促服药,这些因素对CPAT的影响有统计学意义(P<0.05)。而性别、在职状况、医疗费用支付方式、高血压分期、服药种类和数量、医患关系对CPAT的影响没有统计学意义(P>0.05)。结论:门诊高血压患者药物治疗依从性总体水平不高的现象在高血压疾病治疗中普遍存在。 Objective: To Understand and analyze the hypertension drug treatment compliance (CPAT) status and influencing factors.Methods: Using self-prepared questionnaire convenience sampling method to investigate 130 cases of cardiovascular hospital hypertension clinic, the Morisky-Green compliance evaluation tbrm for the determination, statistical analysis using SPSS 11.5 software. Results:(1 ) 130 cases of hypertension were 33.8% higher CPAT (44 cases), moderate by 30% (39 cases), the lower 36.2% (47 cases).(2) CPAT factors: age. marital status, educational level, family income, community medical service stares, duration, disease symptoms, adverse drug reactions, understand the importance of treatment, drug knowledge, understanding, self-test blood pressure, family members urge the medication, these the impact of factors on the CPAT was statistically significant (P〈0.05).And gender, working conditions, payment of medical expenses, hypertension stage, type and quantity of medication, the impact of physician-patient relationship on the CPAT was not statistically significant (P〉 0.05).Conclusions: Outpatient drug treatment in patients with hypertension the overall level of compliance is not the phenomenon of high prevalence in the treatment of hypertension.
作者 陈晨
出处 《中国医药导刊》 2011年第10期1731-1732,共2页 Chinese Journal of Medicinal Guide
关键词 高血压 药物治疗 依从性 Hypertention Drug therapy Compliance
  • 相关文献

参考文献5

二级参考文献33

  • 1全国血压抽样调查协作组.中国人群高血压患病率及其变化趋势[J].高血压杂志,1995,3(A01):7-13. 被引量:508
  • 2Malcolon Rowl Thomas N.Tozer 彭彬 译.临床药动学[M].长沙:湖南科学技术出版社,1999.178~189,253~266.
  • 3Murray J, Lopez AD. Global pattern of cause of death and burden of diseases in 1990, with projections to 2020 investing in health research and development report of the adhoc committee on health research relation to future intervention options. Geneva WHO, 1996.
  • 4Ibrahim M, Rizk H, Appl LJ, et al. Hypertension prevallence, awanagement and control: in egypt, results from the egyptian national hypertension project(NHP). NHP Investigative Team[J]. Hypertension, 1995, 26: 886-890.
  • 5Arroyo P, Fernandez V, Loria A, et al. Hypertension in urban Mexico: the 1992-1993 national survey of chronic diseases[J]. J Human Hypertens, 1999,13:671-675.
  • 6The joint national committee on detection, evaluation, and treatment of high blood pressure. The fifth report of the joint national committee on detection evaluation, and trealrnent of high blood pressure JNC V[J]. Arch Intern Med, 1993,153-154.
  • 7Burt VL, Whelton P, Roccella FJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991[J]. Hypertens, 1995,25: 305-313.
  • 8Stockwell DH, Madhavan S, Cohen H, et al. The determinants of hypertension awareness, treatment, and control in an insured population[J]. AM J Public Health, 1994,84 : 1768
  • 9林金秀,吴可贵.1999年世界卫生组织/国际高血压联盟关于高血压治疗指南[J].高血压杂志,1999,7(2):97-100. 被引量:641
  • 10沈骑.外语教育政策研究的价值之维[J].外语教学,2011,32(2):44-47. 被引量:23

共引文献375

同被引文献64

引证文献8

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部